• Shopping cart is empty.

    The International Society for Aerosols in Medicine


    Who we are & What we do

    The International Society for Aerosols in Medicine (ISAM) was founded in 1970. The objectives of ISAM are to stimulate and further the interdisciplinary cooperation and exchange of information in all aspects of aerosol research in medicine including health effects of inhaled aerosols and pulmonary drug delivery. ISAM sponsors international conferences, publications, study groups and special research projects. To introduce new therapies into practice ISAM has organized educational seminars, and provided advice on basic and advanced levels to staff and international organizations such as the World Health Organization (WHO) and the American Thoracic Society (ATS). ISAM is a non-profit organization.


    Current ISAM Board Members are: Rajiv Dhand, President (USA); Sunalene Devadason, Past-President (Australia); Chantal Darquenne, President-Elect (USA); Andrew Martin, General Secretary (Canada); Sabine Haeussermann, Treasurer (Germany). They are assisted by an international group of 5 additional Board Members: Ira Katz (France), Philip Kuehl (USA), Jim Fink (USA), Otmar Schmid (Germany), and Stephan Ehrmann (France). The Ex Officio member of the Board is Gerald C. Smaldone, JAMPDD Editor (USA). Tim Corcoran is the JAMPDD Associate Editor (USA).

    ISAM sponsors an International Congress every two years. The most recent was held in Santa Fe, NM (USA) in June 2017. The next Congress will be held in Montreux, Switzerland in May 2019. Check this website for further information. In intervening years, Regional Congresses and Focus Symposia on specific topics are organized. If you have a special interest in aerosols, you should consider becoming a member of ISAM. Currently, there are about 250 members. They represent different disciplines connected to aerosols in the lung, e.g. physicians, physicists, biologists, pharmacologists, respiratory care practitioners, engineers and others. Please join us and receive all benefits of membership in ISAM. The society also leverages network groups to foster communication within focus areas and to ensure that the congresses present current and novel information for the membership. The networking groups are focused in the following areas: Regulatory Affairs and Standardization Issues; New Devices and Emerging Therapies; Pediatrics and Cystic Fibrosis; Imaging, Modeling and Physiology of Aerosols in the Lung; Environmental/Occupational Health and Young investigators/early career members. Finally, ISAM fosters and encourages promising new researchers, and recognizes eminent, long-standing career achievements within these areas of interest through a generous awards program.

    The Journal of Aerosol Medicine and Pulmonary Drug Delivery, also known as JAMPDD, is the official Journal of ISAM. Published bimonthly by Mary Ann Liebert Inc., JAMPDD serves as a forum for studies involving inhalation of particles and gases in the respiratory tract, including the use of aerosols as tools to study basic structural and functional phenomena, their use as selective delivery systems for medication and the toxic effects of inhaled agents. Gerald C. Smaldone, MD PhD (Stony Brook, NY) is the Editor, assisted by Tim Corcoran, PhD, Associate editor (University of Pittsburgh, USA) and an international Editorial Board of 37 members. The Journal is indexed by the major electronic indices and available electronically and in hardcopy to members of ISAM.


    ISAM 2021 Congress

    The 2021 Congress of the International Society for Aerosols in Medicine will be held May 22-26 2021 in Boise, Idaho.

    Enjoy the ISAM Congress 2021 inspired by the lovely scenery of Treasure Valley combined with the intellectual rigor of scientists coming from all over the world.